Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Manhattan Scientifics, Inc. (OTC: MHTX).

Full DD Report for MHTX

You must become a subscriber to view this report.


Recent News from (OTC: MHTX)

Magnetic Nanoparticles Leap From Lab Bench to Breast Cancer Clinical Trials
Manhattan Scientifics, Inc. (MHTX) (OTCQB: MHTX) today issued an update on its affiliates' progress regarding its Early Cancer Detection Diagnostic The entire article can be read at this link: https://share-ng.sandia.gov/news/resources/news_releases/magnetic_nanoparticles/#.Wui5fKQvy...
Source: Business Wire
Date: May, 02 2018 10:06
MHTX Provides Corporate Update
Manhattan Scientifics Inc. (MHTX)(OTCQB: MHTX) today issued an update on the status of the company and its technologies. The Company is a substantial owner of two Nanotechnologies. The Company incubated, spun out and IPO'd its Early Cancer Detection diagnostic ( IBX.AX ) following in...
Source: Business Wire
Date: October, 05 2017 10:01
Manhattan Scientifics Announces Successful Completion of its Affiliate Imagion Biosystems IPO
Imagion Biosystems (IBX) to Trade on the Australian (ASX) Stock Exchange Manhattan Scientifics Inc. (MHTX), Imagion Biosystems (IBX) and the National Institute of Health (NIH) collectively have invested over $20M to develop and commercialize the cancer diagnostic nanotechnology origin...
Source: Business Wire
Date: June, 22 2017 09:00
Manhattan Scientifics Schedules Investor Conference Call on Its Affiliate, Imagion Biosystems IPO
Manhattan Scientifics Inc. (OTCQB: MHTX) announced today that it will host a conference call for MHTX investors at 12:00 pm Eastern Time on Friday, June 16, 2017 to provide an update and briefing on the pending Imagion Biosystems IPO (IBX). There will not be a Q&A Session and participant...
Source: Business Wire
Date: June, 14 2017 15:59
Manhattan Scientifics Affiliate Files for Initial Public Offering on Australian Stock Exchange
Manhattan Scientifics Inc. (OTCQB: MHTX) is pleased to announce that its affiliate company, Imagion Biosystems Limited (“Imagion”), formerly known as Senior Scientific, LLC, filed a prospectus with the Australian Securities and Investment Commission and applied to the Australia...
Source: Business Wire
Date: June, 01 2017 09:06
Manhattan Scientifics Announces Retirement of Long-Term Debt
Company Now Has a Virtually Debt-Free Balance Sheet Manhattan Scientifics Inc. (OTCQB:MHTX) announced the retirement of $2.5 million in current debt. The company said it now has a virtually debt-free balance sheet. The $2.5 million debt was owed by MHTX’s subsidiary Se...
Source: Business Wire
Date: February, 14 2017 09:00
Manhattan Scientifics Announces Retirement of its Current $2.5M Long Term Debt and Proudly States That It Now Has a Virtually Zero-Debt Balance Sheet
Manhattan Scientifics Inc. (OTCQB: MHTX) announced today that equity capital to retire $2.0M of the $2.5M debt was raised by Manhattan Scientifics' subsidiary, Imagion Biosystems. The remaining $500,000 debt, currently guaranteed to the lender by Manhattan Scientifics, is scheduled to conver...
Source: Business Wire
Date: February, 13 2017 09:00
Manhattan Scientifics Cancer Diagnostic IPO Update
Manhattan Scientifics Inc. (OTCQB:MHTX) anticipates positive changes resulting from its plan to list the company’s cancer diagnostic unit, Senior Scientific, on the Australian Stock Exchange. The changes include: Retirement of the company’s long-term debt of $2.5M lea...
Source: Business Wire
Date: December, 19 2016 16:55
NetworkNewsBreaks - Top 10 Mid-day Percentage Gainers on November 29, 2016
Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: INCT 149.33% – News: Partners with LeadingEdgeRadio.tv to provide worldwide news via online media platform CBMX 40.74% – News: NY De...
Source: NetworkNewsWire
Date: November, 29 2016 13:00
Manhattan Scientifics Announces Agreement to Spin-Off and IPO its Senior Scientific Unit
Plan to spin-off Senior Scientific to create value for MHTX shareholders Manhattan Scientifics (OTCQB:MHTX) announces that it is implementing a plan to have Senior Scientific, the company’s cancer diagnostic unit, pursue an IPO and listing on the Australian Stock Exchange (AS...
Source: Business Wire
Date: November, 29 2016 09:56

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-200.0230.0210.0230.0202147,500
2018-08-170.01610.0220.0220.0161686,560
2018-08-160.0170.0170.01780.01710,300
2018-08-150.0170.0179750.01840.0177,400
2018-08-140.01870.01860.01870.01712,163

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-2071,000147,50048.1356Short
2018-08-17265,548711,56037.3191Short
2018-08-1610,00010,30097.0874Short
2018-08-156,7007,40090.5405Short
2018-08-1460012,1634.9330Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MHTX.


About Manhattan Scientifics, Inc. (OTC: MHTX)

Logo for Manhattan Scientifics, Inc. (OTC: MHTX)

Manhattan Scientifics Inc. www.mhtx.com is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of transformative technologies in the nano medicine space. The company is presently developing commercial medical prosthetic applications for its ultra fine grain metals.

 

Contact Information

 

 

Current Management

  • Marvin Maslow / Founder
  • Emmanuel Tsoupanarias / CEO, President
  • Marvin Maslow / Chairman
  • Frank Georgiou /
  • Emmanuel Tsoupanarias /

Current Share Structure

  • Market Cap: $8,807,388 - 03/09/2018
  • Authorized: 950,000,000 - 09/30/2016
  • Issue and Outstanding: 533,781,064 - 11/08/2017
  • Float: 322,640,247 - 04/11/2016

 


Recent Filings from (OTC: MHTX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 17 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 05 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 13 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 18 2017
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: August, 15 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 12 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: April, 27 2017

 

 


Daily Technical Chart for (OTC: MHTX)

Daily Technical Chart for (OTC: MHTX)


Stay tuned for daily updates and more on (OTC: MHTX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MHTX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MHTX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of MHTX and does not buy, sell, or trade any shares of MHTX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/